Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Sodium triacetoxyborohydride → 4-[(4-tert-Butylmorpholin-2-yl)methyl]-N-(3,4-dichlorophenyl)piperazine-1-carboxamide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Sodium triacetoxyborohydride | HCID 5049666 | — |
| 반응물 | N-(3,4-Dichlorophenyl)piperazine-1-carboxamide | HCID 16775732 | — |
| 반응물 | 4-Tert-butylmorpholine-2-carbaldehyde | HCID 57656913 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 생성물 | 4-[(4-tert-Butylmorpholin-2-yl)methyl]-N-(3,4-dichlorophenyl)piperazine-1-carboxamide | HCID 57656739 | 19.4% |
반응 단계
A solution of 4-tert-butylmorpholine-2-carbaldehyde (154 mg) and N-(3,4-dichlorophenyl)piperazine-1-carboxamide (247 mg) in dichloromethane (20 mL) was stirred at room temperature under argon. Sodium triacetoxyborohydride (381 mg) was added and the mixture was stirred overnight. The reaction was quenched with water and partitioned between water and dichloromethane. The organic layer was washed with saturated aqueous sodium hydrogen carbonate and then brine, dried (Na2SO4), filtered and concentrated. The residue was purified on the Isco™ Companion (12 g column: 0-11% MeOH in DCM) to give the title compound as a white solid (75 mg).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07906645B2 |
| 출처 데이터셋 | uspto-grants-2011_03 |
| ORD ID | ord-8797c8f9f8764bd697c5284f6f3bada2 |
| 출처 메모 | uspto-grants-2011_03 |